CA 27 29 (Cancer Antigen 27.29) Blood Biomarker Testing
CA 27 29 is a tumor marker mainly used to monitor treated breast cancer over time, with convenient ordering and clear results through Vitals Vault.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
CA 27 29 is a blood test that measures a protein marker (a “tumor marker”) that can be released into the bloodstream by some breast cancer cells. The most common reason it is ordered is to track how things are changing over time after a breast cancer diagnosis and treatment.
This test is not designed to screen for cancer in people without a prior diagnosis, and it cannot confirm or rule out cancer by itself. Your result is most useful when you compare it with your own prior values and interpret it alongside symptoms, imaging, and other labs.
If you are deciding whether to order CA 27 29, the key question is whether you need trend data for monitoring. A single number can be confusing, but a pattern—especially when measured consistently—can help you and your clinician decide what to do next.
Do I need a CA 27 29 test?
You are most likely to benefit from CA 27 29 testing if you have a history of breast cancer and you and your clinician are monitoring for treatment response or possible recurrence. In that setting, the test can add information when it is repeated over time and interpreted in context.
You might also see it ordered if you have metastatic (advanced) breast cancer and your care team wants another data point to follow disease activity. Some clinicians use CA 27 29 alongside other markers (such as CA 15-3 or CEA) to improve confidence in trends.
CA 27 29 is usually not the right test if your goal is general cancer screening or figuring out the cause of vague symptoms without a known cancer diagnosis. Many non-cancer conditions can raise this marker, and some breast cancers do not raise it at all.
If you are unsure whether it applies to you, treat CA 27 29 as a monitoring tool rather than a diagnostic answer. Testing can support clinician-directed care, but it is not a substitute for a full evaluation.
CA 27 29 is measured on validated clinical laboratory platforms (CLIA-certified); results should be interpreted with your clinical history and are not a standalone diagnosis.
Lab testing
Order a CA 27 29 test to establish a baseline or recheck a prior value
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
If you and your clinician want an easy way to track CA 27 29 over time, Vitals Vault lets you order the lab and keep your results organized for trend review. Consistent testing (same marker, similar timing, and a comparable lab method when possible) makes your changes easier to interpret.
After you receive your result, you can use PocketMD to ask practical questions like whether a change is meaningful, what follow-up tests are commonly paired with CA 27 29, and how soon a repeat test might make sense based on your situation.
This is especially helpful if you are coordinating care across multiple visits or you want a clear record of your baseline and subsequent values. You stay in control of ordering and can share results with your care team for medical decision-making.
- Order labs directly and view results in one place for easier trending
- PocketMD helps you turn a number into next-step questions for your clinician
- Designed for monitoring and follow-up planning, not one-off guesswork
Key benefits of CA 27 29 testing
- Helps you track a personal baseline and trend after breast cancer treatment.
- Can provide an early signal of change when values rise consistently over multiple tests.
- Supports treatment monitoring in metastatic breast cancer when your tumor produces this marker.
- Adds context when paired with symptoms, imaging, and other tumor markers rather than used alone.
- May help you and your clinician decide when a closer follow-up interval is reasonable.
- Can reduce uncertainty by distinguishing a one-time fluctuation from a sustained pattern.
- Makes it easier to keep longitudinal records and ask focused questions in PocketMD.
What is CA 27 29?
CA 27 29 (Cancer Antigen 27.29) is a blood-based tumor marker that reflects fragments of a larger protein called MUC1. Some breast cancer cells shed MUC1-related material into the bloodstream, which is what the CA 27 29 assay detects.
The key point is that CA 27 29 is not specific enough to diagnose cancer on its own. Levels can be normal in people with breast cancer, and levels can be elevated for reasons that have nothing to do with cancer. That is why clinicians mainly use it for monitoring—watching how your result changes compared with your own prior results.
When CA 27 29 is useful, it is usually because your tumor biology produces the marker and your values move in a consistent direction with changes in disease activity. If your marker has never been elevated, it may not be a helpful monitoring tool for you.
How it is used in real life
CA 27 29 is most often used after a breast cancer diagnosis to follow response to therapy or to help evaluate possible recurrence when there is already a clinical reason to look closer. It is typically interpreted alongside imaging findings and your symptoms, not as a standalone “yes/no” result.
Why trends matter more than one result
A single CA 27 29 value can be misleading because normal ranges vary by lab and because benign conditions can cause temporary elevations. Repeating the test at consistent intervals helps you see whether the marker is stable, drifting upward, or returning toward your baseline.
What do my CA 27 29 results mean?
Low CA 27 29 levels
A low CA 27 29 result is usually reassuring, especially if it is similar to your prior baseline. However, a low value does not rule out breast cancer or recurrence because not all tumors produce this marker. If you have symptoms or imaging concerns, your clinician will rely on those findings rather than the marker alone.
In-range (typical) CA 27 29 levels
An in-range result generally means the marker is not elevated on this test, but the most important comparison is still your own prior values. If your CA 27 29 has been a reliable marker for you, stability over time can support a “no major change” interpretation. If this is your first test, it functions mainly as a baseline for future comparison.
High CA 27 29 levels
A high CA 27 29 result does not automatically mean cancer has returned or progressed, but it does warrant context. Clinicians often look for a sustained rise across repeat tests rather than reacting to one elevated value. If the marker is rising and you have supporting clinical findings, your care team may consider additional evaluation such as repeat testing, imaging, or other tumor markers.
Factors that influence CA 27 29
CA 27 29 can be affected by non-cancer conditions, including some benign breast conditions, liver disease, inflammation, and other cancers, which can lead to false positives. Lab-to-lab differences, assay method changes, and timing (for example, testing too soon after treatment changes) can also shift results. Because of this, it helps to test consistently and interpret changes with your full clinical picture rather than focusing on a single cutoff.
What’s included
- Ca 27.29
Frequently Asked Questions
What is a normal CA 27 29 level?
“Normal” depends on the lab’s reference interval, so the best starting point is the range printed next to your result. For monitoring, your clinician often focuses more on how your value changes over time compared with your own baseline than on a single number.
Is CA 27 29 used to screen for breast cancer?
CA 27 29 is not recommended as a general screening test. It can be elevated for non-cancer reasons and can be normal even when breast cancer is present, so it is mainly used to monitor people with a known breast cancer diagnosis.
How often should CA 27 29 be repeated?
Retest timing depends on why you are checking it (routine monitoring vs evaluating a change) and what other information you have, such as symptoms or imaging. Many clinicians repeat tumor markers on a schedule that matches your follow-up plan and may confirm an unexpected rise with a repeat test before acting.
Can CA 27 29 be high for reasons other than cancer?
Yes. Benign conditions and inflammation can raise CA 27 29, and other cancers can also elevate it. That is why an isolated high result usually leads to confirmation and context-building rather than an immediate conclusion.
Do I need to fast for a CA 27 29 blood test?
Fasting is not typically required for CA 27 29. If you are getting other labs at the same visit (such as lipids or glucose-related tests), those may have fasting requirements, so follow the instructions for your full order.
What is the difference between CA 27 29 and CA 15-3?
Both are tumor markers related to the MUC1 protein family and are often used for similar monitoring purposes in breast cancer. Some clinicians prefer one over the other based on lab availability and how well the marker tracks your individual disease; the most important factor is whether the marker reliably trends for you.
If my CA 27 29 is rising, does that mean my cancer is back?
Not necessarily. A rising trend can be a reason to look closer, but it is not definitive on its own. Your clinician will consider repeat testing, the size and speed of the rise, your symptoms, exam findings, and imaging before drawing conclusions.